Mergers & Acquisitions

Creating Rite Aid pharmacies within Albertsons banners will help the pair fold into more narrow networks, executives said.

Specialty pharmaceutical company Aquestive Therapeutics has reached a settlement agreement resolving patent litigation related to Suboxone (buprenorphine and naloxone) Sublingual Film.

Adello Biologics, a U.S.-based biotechnology company headquartered in Piscataway, N.J., has named Amneal co-chairman Chintu Patel as CEO, effective immediately. Patel succeeds Peter Moesta, who is stepping down to pursue other opportunities.

Albertsons’ dietitians engage customers through the company’s “Answers in the Aisles” program, where dietitians schedule supermarket walk-throughs to educate participants on how to best fight inflammation through food, for example.

Marisa Iasenza, previously the senior vice president of general counsel and secretary at Harman International Industries, was named the new chief legal officer for Edgewell Personal Care.

Henkel will acquire JemPak, a Canada-based company that specializes in the laundry and home care space, for $118 million Canadian dollars.

With its acquisition of Impax Labs complete, Amneal is looking to streamline its operations with a plan to phase out its Hayward, Calif., facilities over the course of 15 months.

Brian Griffin will join Diplomat as CEO and chairman, effective June 4, from his position as at Anthem as executive vice president and CEO of its pharmacy benefits manager IngenioRx.